Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.
about
Advanced MRI and staging of multiple sclerosis lesionsExamination of the role of magnetic resonance imaging in multiple sclerosis: A problem-orientated approach.Interferon-beta1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis.Neuroimaging in multiple sclerosis: neurotherapeutic implications.Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosisWhat do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force.Spring cleaning: time to rethink imaging research lines in MS?Association between seasonal factors and multiple sclerosis.Insights from Ultrahigh Field Imaging in Multiple Sclerosis.Antidyskinetic drug therapy for pediatric movement disorders.Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.Acute disseminated encephalomyelitis and multiple sclerosis: magnetic resonance imaging differentiation.
P2860
Q30825494-FAFCCBF2-AC19-446D-80A5-D534FB3F8F02Q33534161-353A02FA-A296-4314-AFEF-8E64A99A3CF3Q33579409-06925B89-7BAD-4EEE-B835-4483B9385F24Q33806032-A10BD43E-62CE-4B07-ACDF-276F554A50FCQ33899917-02E63C44-F59B-4A90-A81D-7E7415123271Q36318289-1F9B1127-00DB-4CD2-9E76-7D00EA879EE9Q36396476-A2976C39-D7AA-4E94-B7D7-B123F93EDAB6Q36814514-CEFC4AF9-3B66-4020-975D-DCDAA1F62A13Q36887909-5F7D7CED-0DA1-4668-B3BA-E10E1B33AB03Q38737202-AF1AC8B6-0E7F-4665-A883-55B6FC96D99CQ38844507-284871BE-4F32-49F6-9FAD-CB937B5F684CQ39229796-E63DF0A9-9DD4-4DBC-A9BC-FC3F409E6C88Q41172780-B4E1B449-C687-46C1-B01F-057535DAC6F1Q48232899-CC4A39D7-13F5-4831-A9D0-E92134149D1FQ48866045-FBCFBDB4-CD7C-4211-AB50-B5F9220D1C99Q54321783-78D9D64E-1237-4C68-805D-0F089311DC7B
P2860
Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Serial contrast-enhanced magne ...... ications for treatment trials.
@en
Serial contrast-enhanced magne ...... ications for treatment trials.
@nl
type
label
Serial contrast-enhanced magne ...... ications for treatment trials.
@en
Serial contrast-enhanced magne ...... ications for treatment trials.
@nl
prefLabel
Serial contrast-enhanced magne ...... ications for treatment trials.
@en
Serial contrast-enhanced magne ...... ications for treatment trials.
@nl
P2093
P356
P1433
P1476
Serial contrast-enhanced magne ...... ications for treatment trials.
@en
P2093
P304
P356
10.1002/ANA.410360719
P478
P577
1994-01-01T00:00:00Z